Injective

Injective is the first and only blockchain built for finance. It is an open, interoperable layer-one blockchain powering next-generation finance applications, including DeFi, RWAs, AI, decentralized exchanges, prediction markets, lending protocols, and more.

Injective uniquely provides powerful core financial infrastructure primitives that applications can leverage, including a fully decentralized MEV-resistant on-chain orderbook. Developers can utilize Injective’s plug-and-play modules to rapidly deploy applications that could take years on other chains. Injective is also one of the most interoperable L1s ever created which is fully compatible with major chains such as Ethereum and Solana.

Injective also provides a next-generation, highly interoperable smart contract platform based on Wasm 2.0, with advanced interchain capabilities. Injective utilizes a custom implementation of the Tendermint Proof-of-Stake consensus mechanism, providing instant transaction finality with lightning speed – sub second block times (0.6s) while sustaining enormous throughput (25,000+ TPS). Injective currently is also leading new forms of innovation across a number of verticals such as its pioneering work to integrate artificial intelligence with on-chain finance.

Injective has achieved a historic milestone of over 1 billion transactions to date with one of the fastest chains built to date. The Injective ecosystem includes 100+ projects and over 500,000 community members globally. Injective was originally incubated by Binance and is also backed by a group of prominent investors including Pantera Capital, Jump Crypto, and Mark Cuban.

Injective comprises four principal components:

The Injective Chain is a public blockchain network custom-built to support the next generation of on-chain finance applications. Injective utilizes a custom implementation of Tendermint consensus, and the core protocol logic is implemented through native modules and smart contracts on the Wasm smart contract layer. Injective also has launched a new MultiVM initiative to bring new virtual machines to its platform to enable any developer to build on Injective.

Injective provides a decentralized cross-chain bridging infrastructure with over 23 different networks, including prominent chains like Ethereum and Solana.

Injective’s Ethereum bridge is decentralized and secured by the validators of the Injective chain – powered by Injective’s custom peggy bridge system. Additionally, as an IBC-enabled blockchain, Injective supports cross-chain bridging with any other IBC-enabled blockchain, allowing developers and users to access assets from hundreds of other blockchains.

The Injective API offers two primary ways to interact with Injective, the Chain API and the Indexer API. Both APIs offer distinct capabilities. The Chain API is ideal for direct chain interaction, while the Indexer API provides enhanced data accessibility and user-friendly services for dApps.

Injective is a decentralized network allowing individuals to access both the blockchain and dApps built on-chain in a permissionless manner. A multitude of innovative dApps are currently live and surging in usage on Injective ranging from decentralized exchanges to real world asset (RWA) platforms. In fact, Helix which is Injective’s leading DEX has already processed over $40 Billion to date. Beyond this, Injective also powers several other decentralized applications, including dApps for perpetuals, AI, prediction markets, options and more.

Robust Liquidity: Onboard users into your applications with broad liquidity support from day one to maximize capital efficiency. Injective offers a shared liquidity environment that is supported by a thriving community and integrated with the most prominent financial institutions.

Injective Labs is one of the contributors to Injective, the blockchain built for finance.

Eric Chen is the CEO and Co-founder of Injective Labs, a research and development company. Eric’s passion for crypto and blockchain started with mining Ethereum and participating in cryptographic research in college while studying finance and computer science. After working at a major crypto hedge fund, he decided to drop out of college and founded Injective Labs together with Albert Chon (CTO).

INJ is the native utility and governance token of Injective. INJ is a scarce asset that is used for governance, token burn auctions and staking on the PoS network.

The burn auctions on Injective are especially unique since 60% of all fees collected from dApps are auctioned off every week via a buy back and burn mechanism. This in turn allows the supply of INJ to dramatically decrease over time. The INJ burn auction is unique in that it helps accrue value for the entire Injective ecosystem. Currently, Injective has the highest token burn ratio in the industry.

The use cases intended for INJ include but are not limited to: protocol governance, dApp value capture, Proof-of-Stake (PoS) security, developer incentives and staking. Further details regarding each of these use cases can be found below.